Evidence map›Paper›PMID 42221228›Full record

ReviewJournal of human immunity2026

How I Treat: STAT3 hyper IgE syndrome.

Cliodhna Ella Murray, Eyad Jannoud, Seraina Prader, Bodo Grimbacher

Abstract readReview
In one paragraph

Review in Journal of human immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Fungal Infections in Disorders of Inborn Errors of Immunity.Clinical reviews in allergy & immunology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cliodhna Ella MurrayClinic of Rheumatology and Clinical Immunology, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg im Breisgau, Germany.ORCID https://orcid.org/0000-0001-9844-6294
Eyad JannoudClinic of Rheumatology and Clinical Immunology, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg im Breisgau, Germany.ORCID https://orcid.org/0009-0002-6033-8663
Seraina PraderDivision of Immunology, University Children's Hospital Zurich, Zurich, Switzerland.ORCID https://orcid.org/0000-0002-2950-5411
Bodo GrimbacherClinic of Rheumatology and Clinical Immunology, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg im Breisgau, Germany.ORCID https://orcid.org/0000-0002-6897-6806

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STAT3 hyper IgE syndrome (STAT3-HIES) is a rare inborn error of immunity characterized by chronic eczema, recurrent bacterial and fungal infections, markedly elevated serum IgE levels, and a broad spectrum of skeletal, dental, vascular, and gastrointestinal manifestations. Despite increasing insight into the genetic and immunologic basis of STAT3-HIES, detailed, treatment-oriented guidance for clinical practice remains limited. This article provides a pragmatic management guideline for STAT3-HIES. Clinical and laboratory criteria that should prompt suspicion and select patients for genetic testing are discussed. The therapeutic sections cover acute and prophylactic antibacterial treatment, antimicrobial eradication strategies, antifungal therapy, and immunoglobulin replacement therapy. The treatment of severe eczema, organ-specific care for lung, skeletal, vascular, and dental involvement, vaccinations, and supportive measures including physiotherapy and psychosocial support, as well as approaches to pregnancy management, family planning, and genetic counseling are outlined. Furthermore, hematopoietic stem cell transplantation is discussed. This management-focused approach complements existing reviews and aims to standardize care for patients with STAT3-HIES across centers and disciplines.

Identifiers

PMID42221228
PMCPMC13220966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.